Background
==========

Cataract, a loss of the normal transparency of the crystalline lens due to an opacity (lens opacity or crystalline opacity), is one of the leading causes of blindness worldwide \[[@B1],[@B2]\]. Hence, identification of the risk factors is of great importance for prevention and treatment of the blindness. Pollreisz \[[@B3]\] propose in a review article that diabetes is one of the widely perceived risk factors for cataract. Diabetes patients are more prone to develop cataracts \[[@B2]\]. The cataract incidence was estimated 3.31 per 1000 person-years of type 2 diabetic patients during 3.6 years' follow-up \[[@B4]\]. However, studies \[[@B5]-[@B8]\] found that not all types of cataracts \[[@B9]\], nuclear sclerosis (NS), cortical cataract (CC) or posterior subcapsular (PSC), are more prone to occurring in type 2 diabetes (T2D) patients. Evidence for their association has not been systematically assessed.

Therefore, we performed this meta-analysis to explore the association between T2D and the risk of cataract. We anticipate the findings of this study will provide reliable evidence for clinical cataract research and prevention.

Methods
=======

Search strategy
---------------

The databases included PubMed, Embase and SpringerLink and the studies had to be published before November 2013. Only the articles written in English were screened. The key words were consisted of three parts: 1) cataract OR lens opacity OR crystalline opacity; 2) diabetes OR T2DM OR type 2 diabetes; 3) risk OR incidence.

The eligible criteria
---------------------

Inclusion criteria were: (1) the study was designed as observational study (cross-sectional, case--control or cohort study); (2) the study explored the relationship between T2D and the risk of cataracts; (3) there was control group; (4) the outcomes include incidence of cataracts (AC, CC, NS and PSC); (5) the study provided enough information for calculating the Odds Ratio (OR) and 95% confidence interval (CI); (6) if there were multiple articles with same population or data, only the article with the longest follow-up and complete data was selected.

Exclusion criteria were: (1) the study with type 1 diabetes mellitus patients was excluded; (2) all duplicates were excluded; and (3) review articles, letters and comments were also excluded.

Study selection and quality assessment
--------------------------------------

Two investigators independently retrieved the eligible studies according to the search strategy and eligible criteria. The references were managed by Endnote software (Thomson ISI ResearchSoft, Carlsbad, CA, USA). Besides, the manual search was performed to retrieve some more eligible studies in the reviews and references of included studies. The quality of the selected studies were assessed by STROBE statement \[[@B10]\] including 22 items.

Data extraction
---------------

Study characteristics, including first author, publication year, study design, country, diagnosis of cataract and diabetes, age/gender of patient, were extracted independently by two researchers. The odds ratios (ORs) and 95% confidence intervals (CIs) of the exposures were extracted. The statistical methods of covariates adjustment were also noted. Any disagreement was resolved by discussion.

Heterogeneity test
------------------

The heterogeneity between studies was evaluated by *Q* test \[[@B11]\] and *I*^*2*^ statistics \[[@B12]\], where, *P* \> 0.05 and/or *I*^*2*^ \< 50% was considered homogeneity, and a fixed-effect model was used for calculate pooled effect; otherwise, there was significant heterogeneity and random-effect model was used.

Pooled analysis
---------------

The meta-analysis was stratified for different types of cataract definition: AC, CC, NS and PSC. The pooled effect of each exposure on T2D was estimated by the values of ORs and 95% CIs. If the ORs were provided in the publications, they were used for pooled estimate. Otherwise, the ORs were calculated according to the provided data in the articles. All statistical analyses were conducted by Stata 11.0 software.

Sensitivity analysis and publication bias estimate
--------------------------------------------------

The sensitivity analysis was conducted to test the robustness of the results by: 1) only the cross-sectional studies were included; 2) only the studies with Eye examination to confirm the cataract were included. The publication bias was estimated by Begg's test \[[@B13]\] and Egger's test \[[@B14]\], using a significance level of *P* \< 0.05 to indicate significant asymmetry.

Results
=======

Study selection
---------------

The process of literature search and study selection was displayed in Figure  [1](#F1){ref-type="fig"}. By retrieval of PubMed, Embase and SpringerLink databases according to the search strategy, 771, 238 and 677 documents were obtained, respectively. After excluding the duplicates, 1037 articles remained. By screening the title, we excluded 1014 documents that did not meet the inclusion criteria. Then by reading the abstracts 10 studies were excluded (3 without control group; 1 outcome was not incidence of cataract; 6 did not investigated the relationship between T2D and cataract). Then in the remaining 13 studies, we reviewed the full text and 5 studies were excluded including 1 with non T2D subjects, 3 with incomplete data and 1 with duplicated crowd. Finally, 8 studies \[[@B5]-[@B7],[@B15]-[@B19]\] were included in this meta-analysis.

![Literature search and study selection.](1471-2415-14-94-1){#F1}

The characteristics of the included studies
-------------------------------------------

The characteristics of the included studies were listed in Table  [1](#T1){ref-type="table"}. All studies are with high quality (17--21 STROBE scores, Additional file [1](#S1){ref-type="supplementary-material"}: Table S1). Among the 8 include studies there were 6 cross-sectional studies \[[@B5]-[@B7],[@B15],[@B17],[@B18]\], 1 cohort study \[[@B19]\] and 1 case--control study \[[@B16]\], including 20837 subjects. Since Jacques' study \[[@B5]\] did not provide the specific number of cases, so we could not obtain the accurate total number of cases in this meta-analysis. The area distributions of the 8 studies were: 2 in Europe (France and Sweden), 3 in American, 1 in African and one in Australian. Seven articles reported three kinds of outcomes of NS, CC and PSC. Five studies reported the overall incidence of any cataract (AC). Six literatures provided adjusted OR and 95% CI, two studies provided OR calculable data.

###### 

Characteristics of 8 studies on type 2 diabetes and cataract

  **Author year**                     **Location**   **Ascertainment of cataract**   **Type of study**   **Ascertainment of diabetes**   **Definition of cataract**               **Age(y) sex**   **Outcome**   **No. of case**   **Diabetes**   **No. of case**   **Non- diabetes**   **ORs (95% CI)**      **Adjustment for covariates**                                                                                                  **STROBE scores**
  ----------------------------------- -------------- ------------------------------- ------------------- ------------------------------- ---------------------------------------- ---------------- ------------- ----------------- -------------- ----------------- ------------------- --------------------- ------------------------------------------------------------------------------------------------------------------------------ -------------------
  Machan 2012 \[[@B8]\]               French         Hospital records                Cross- sectional    Hospital records                LOCS II                                  \<1-93 M&F       AC            348               452            1885              5884                1.60 (1.13, 2.27)     Age, gender, smoking, systolic blood pressure, Statin use                                                                      20
                                                                                                                                                                                                   NS            282                              1546                                  1.62 (1.14, 2.29)                                                                                                                                     
                                                                                                                                                                                                   CC            104                              525                                   1.37 (1.02, 1.83)                                                                                                                                     
                                                                                                                                                                                                   PSC           44                               194                                   1.33 (0.90, 1.96)                                                                                                                                     
  Tan et al. 2008 \[[@B19]\]          Australia      Eye examination                 Cohort              Medical record or IFG test      Wisconsin Cataract Grading System        ≥49 M&F          NS            37                69             402               1149                6.76 (1.04,14.00)\*   Age, gender, smoking, myopia, and pulse pressure, sun-related skin damage, ever use of steroids, myopia, and body mass index   21
                                                                                                                                                                                                   CC            32                95             443               1642                1.60 (0.78, 4.87)\*                                                                                                                                   
                                                                                                                                                                                                   PSC           15                112            162               1844                1.56 (0.72, 3.79)\*                                                                                                                                   
  Rotimi et al. 2003 \[[@B18]\]       West African   Eye examination                 Cross- sectional    IFG test                        ---                                      ≥20 M&F          AC            373               831            35                191                 3.63 (2.45, 5.37)\*   Crude                                                                                                                          18
  Olafsdottir et al. 2012 \[[@B7]\]   Sweden         Eye examination                 Cross- sectional    IFG test                        LOCS II score ≥ 2                        24-93y M&F       AC            208               275            175               256                 1.44 (0.98,2.10)\*    Crude                                                                                                                          20
                                                                                                                                                                                                   NS            132                              131                                   0.88 (0.63,1.24)\*                                                                                                                                    
                                                                                                                                                                                                   CC            180                              131                                   1.81 (1.28,2.56)\*                                                                                                                                    
                                                                                                                                                                                                   PSC           117                              83                                    1.54 (1.08,2.20)\*                                                                                                                                    
  Jacques et al. 2003 \[[@B5]\]       USA            Eye examination                 Cross- sectional    IFG test                        LOCS III ≥2.5, NS; ≥1.0, CC; ≥0.5,PSC    54-73 F          NS            NR                31             NR                400                 1.5 (0.6, 3.5)        Age, smoking , summertime sunlight exposure, and alcohol intake                                                                21
                                                                                                                                                                                                   CC                                                                                   1.2 (0.6, 2.6)                                                                                                                                        
                                                                                                                                                                                                   PSC                                                                                  4.1 (1.8, 9.4)                                                                                                                                        
  Klein et al. 1995 \[[@B6]\]         USA            Eye examination                 Cross- sectional    Medical record or IFG test      Wisconsin Cataract Grading System        43-84 M&F        NS            66                384            570               4285                0.93 (0.67,1.29)      Age, gender                                                                                                                    17
                                                                                                                                                                                                   CC            81                               471                                   1.72 (1.29,2.30)                                                                                                                                      
                                                                                                                                                                                                   PSC           19                               165                                   1.09 (0.66,1.78)                                                                                                                                      
  Leske et.al. 1999 \[[@B16]\]        USA            Eye examination                 Case- control       Medical record or IFG test      LOCS II grade ≥ 2                        40-84 M&F        AC            1800              448            2431              289\#               1.85 (1.51, 2.27)     Age, gender                                                                                                                    18
                                                                                                                                                                                                   NS                              48                                                   1.35 (0.89, 2.05)                                                                                                                                     
                                                                                                                                                                                                   CC            229               201                                                  1.74 (1.39, 2.18)                                                                                                                                     
                                                                                                                                                                                                   PSC           851               4                                                    1.88 (0.61, 5.79)                                                                                                                                     
                                                                                                                                                                                                                 17                                                                                                                                                                                                                           
  Foster et al. 2003 \[[@B15]\]       Singapore      Eye examination                 Cross- sectional    Medical record                  LOCS III ≥ 4 NS ≥ 2 for CC ≥ 2 for PSC   40-81 M&F        AC            NR                27             NR                1066                2.0 (0.9, 4.5)        Age, gender, body mass index and occupation.                                                                                   21
                                                                                                                                                                                                   NS                                                                                   2.8 (0.8, 9.4)                                                                                                                                        
                                                                                                                                                                                                   CC                                                                                   3.1 (1.6, 6.1)                                                                                                                                        
                                                                                                                                                                                                   PSC                                                                                  2.2 (1.2, 4.1)                                                                                                                                        

\*: ORs was calculated based on literature data; AC: any cataract; NS: nuclear sclerosis; CC: cortical cataract; PSC: posterior subcapsular cataract; NR: not recorded; LOCS, lens opacities classification system \#: number of diabetes.

Meta-analysis of the risk of cataract in T2D patients
-----------------------------------------------------

By heterogeneity analysis of the five studies \[[@B7],[@B15]-[@B18]\] that reported the overall incidence of AC, there were significant heterogeneity among studies (*I*^2^ = 70.4%, *P* = 0.009), and a random-effect model was used for estimate of the pooled effect. It was showed that (Figure  [2](#F2){ref-type="fig"}) the OR of AC risk between T2D patients and non-diabetic subjects was 1.97 (95% CI: 1.45-2.67, *P* \< 0.001), indicating that the risk of AC was significantly elevated in T2D patients compared with non-diabetic subjects.

![Forest plot of the association between type 2 diabetes and any cataract.](1471-2415-14-94-2){#F2}

Figures  [3](#F3){ref-type="fig"}, [4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"} showed the pooled results of three types of cataract \[[@B5]-[@B7],[@B15]-[@B17],[@B19]\], NS, CC and PSC, in T2D patients. There was significant heterogeneity among studies of NS and T2D patients (*I*^2^ = 65.8%, *P* = 0.007), and a random-effect model was used to produce an OR of 1.36 (95% CI: 0.97-1.90, *P* = 0.070), indicating a higher risk of NS in T2D patients over non-T2D patients. There was no significant heterogeneity among studies of CC (*I*^2^ = 3.3%, *P* = 0.400) and PSC (*I*^2^ = 34.9%, *P* = 0.162), and fixed-effect models were used. The pooled ORs were respectively 1.68 for CC (95% CI: 1.47-1.91, *P* \< 0.001) and 1.55 for PSC (95% CI: 1.27-1.90, *P* \< 0.001). These results indicated that patients with T2D had a higher risk of cataracts than those without.

![Forest plot of the association between type 2 diabetes and nuclear sclerosis.](1471-2415-14-94-3){#F3}

![Forest plot of the association between type 2 diabetes and cortical cataract.](1471-2415-14-94-4){#F4}

![Forest plot of the association between type 2 diabetes and posterior subcapsular cataract.](1471-2415-14-94-5){#F5}

Sensitivity analysis and publication bias estimate
--------------------------------------------------

The result of sensitivity analysis indicated that the results of the present meta-analysis were robust (Table  [2](#T2){ref-type="table"}). The pooled results for the outcomes of cross-sectional studies or the studies with Eye examination for cataract diagnosis were consistent with those before sensitivity analysis.

###### 

Sensitivity analysis of meta-analysis of type 2 diabetes and cataract risks

  **Outcomes**   **Pooled OR (95%CI)**   ***P***~**A**~   ***P***~**H**~    **Sensitivity analysis**                                                 
  -------------- ----------------------- ---------------- ---------------- -------------------------- --------- ------- ------------------ --------- -------
  Any Cataract   1.97(1.45, 2.67)        \<0.001          0.009                 2.02(1.27, 3.21)      0.003     0.004   2.09(1.41, 3.09)   \<0.001   0.008
  NS             1.36(0.97, 1.90)        0.070            0.007                 1.20(0.86, 1.69)      0.288     0.040   1.31(0.89, 1.93)   0.164     0.017
  CC             1.68(1.47, 1.91)        \<0.001          0.400                 1.65(1.39, 1.94)      \<0.001   0.196   1.77(1.52, 2.05)   \<0.001   0.564
  PSC            1.55(1.27, 1.90)        \<0.001          0.162                 1.54(1.25, 1.90)      \<0.001   0.059   1.64(1.30, 2.07)   \<0.001   0.136

*P*~A~: *P*~value~ of association; *P*~H~: *P*~value~ of Heterogeneity. AC: any cataract; NS: nuclear sclerosis; CC: cortical cataract; PSC: posterior subcapsular cataract.

Begg's test and Egger's test showed no significant publish bias among studies (*P* \> 0.05, Table  [3](#T3){ref-type="table"}).

###### 

The results of publication bias estimate

        **Begg's test**   **Egger's test**
  ----- ----------------- ------------------
  AC    0.806             0.790
  NS    0.368             0.200
  CC    1.000             0.906
  PSC   0.368             0.198

Data were represented with *P* value.

AC: any cataract; NS: nuclear sclerosis; CC: cortical cataract; PSC: posterior subcapsular cataract.

Discussion
==========

Cataract is a major cause of blindness worldwide, and it largely results from occurrence of diabetes. The present meta-analysis with a substantial number of subjects (20837 subjects) indicated the risk of cataracts was elevated in T2D patients compared with the non-diabetic subjects.

It was reported that cataract is one of the most common complications of diabetes mellitus on the eye \[[@B20],[@B21]\] and up to 20% of all cataract procedures are performed for diabetic patients \[[@B22]\]. Cataracts were more frequently in patients with diabetes \[[@B23],[@B24]\]. In the present study, approximate 2 times risk of AC was found in T2D patients compared with the non-diabetic subjects. Visual improvement was seen following extracapsular cataract extraction surgery for advanced cataract in diabetics and postoperative monitoring for treatment of diabetic retinopathy may enhance visual outcome \[[@B25]\].

A Waterloo Eye Study by reviewing of 6397 clinic files found that diagnosis of T2D resulted in an earlier development of all three cataract subtypes \[[@B8]\]. Similarly in the present study, we found that the risks of CC and PSC were elevated for patients with the T2D (*P* \< 0.05). However, we did not find significant association between T2D and risk of NS. Olafsdottir \[[@B7]\] and Klein \[[@B6]\] reported rather different results about NS from other included studies, which are the main sources of the high heterogeneity, however, they draw similar conclusions in CC and PSC with other included studies. These results highlight the necessary of regular eye examination in T2D patients.

Klein *et al.*\[[@B26]\] indicated that glycemia may be the risk factor of cataracts in T2D patients. Three molecular mechanisms may be involved in the development of diabetic cataract: nonenzymatic glycation of eye lens proteins, oxidative stress, and activated polyol pathway in glucose disposition \[[@B27]\]. In addition, a genetic study showed that three single-nucleotide polymorphisms (SNPs) in chromosome 3p14.1-3p14.2 which related to functions of voltage-dependent anion-selective channel protein, long myosin light chain kinase, adenylyl cyclase-associated protein, and retinoic acid receptor were significantly different in the T2D with cataracts and T2D without cataracts groups \[[@B28]\].

There were limitations in this meta-analysis. Although ORs were corrected by taking account of influences of age, sex and smoking in some included studies, the pooled results might also be influenced by other factors, for instance different treatments of T2D, regions of studies, and body mass index (BMI). Significant heterogeneity still exists among studies, which might be caused by the above factors. In addition, the different methods of definition of cataract (LOCS III, LOCS II, and Wisconsin Cataract Grading System) in deferent studies might also be an important source of heterogeneity.

Conclusion
==========

In summary, the present meta-analysis of five included studies involving 20837 subjects suggests that T2D is a risk factor of cataract, especially CC and PSC. The findings here attract attentions to the importance of regular ophthalmic extermination in T2D. However, the conclusions need more experimental verification.
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